Guardian Pharmacy Services, Inc. Operating Cash Flow
Guardian Pharmacy Services, Inc. (GRDN) reported Operating Cash Flow of $36.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Guardian Pharmacy Services, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $30.02M, a 50.61% increase year-over-year.
- Guardian Pharmacy Services, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $6.06M, a 65.46% decline year-over-year.
- Guardian Pharmacy Services, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $34.60M, a 54.90% increase year-over-year.
- Guardian Pharmacy Services, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $28.17M.
- Guardian Pharmacy Services, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $100.25M, a 72.97% increase from fiscal 2024.
- Guardian Pharmacy Services, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $57.96M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $30.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $36.09M 10-Q · filed 2026-08-06 | $70.69M derived: sum of 3 quarters · filed 2026-08-06 | $98.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $6.06M 10-Q · filed 2026-05-06 | $40.66M derived: sum of 2 quarters · filed 2026-05-06 | $68.83M derived: sum of 3 quarters · filed 2026-05-06 | $88.77M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $34.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $62.77M derived: sum of 2 quarters · filed 2026-03-11 | $82.70M derived: sum of 3 quarters · filed 2026-08-06 | $100.25M 10-K · filed 2026-03-11 |
| 2025-09-30 | $28.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $48.10M derived: sum of 2 quarters · filed 2026-08-06 | $65.66M 10-Q · filed 2025-11-10 | $87.99M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $19.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $37.49M 10-Q · filed 2026-08-06 | $59.82M derived: sum of 3 quarters · filed 2026-08-06 | $57.66M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $17.55M 10-Q · filed 2026-05-06 | $39.89M derived: sum of 2 quarters · filed 2026-05-06 | $37.72M derived: sum of 3 quarters · filed 2026-05-06 | $66.86M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $22.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $20.17M derived: sum of 2 quarters · filed 2026-03-11 | $49.31M derived: sum of 3 quarters · filed 2026-03-11 | $57.96M 10-K · filed 2026-03-11 |
| 2024-09-30 | -$2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $26.97M derived: sum of 2 quarters · filed 2025-11-10 | $35.62M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $29.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $37.79M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $8.65M 10-Q · filed 2025-05-12 | |||
| 2023-09-30 | $56.27M 10-Q · filed 2024-11-12 |